z-logo
Premium
TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins
Author(s) -
Kanai Fumihiko,
Marignani Paola A.,
Sarbassova Dilara,
Yagi Ryohei,
Hall Randy A.,
Donowitz Mark,
Hisaminato Akihiko,
Fujiwara Tsutomu,
Ito Yoshiaki,
Cantley Lewis C.,
Yaffe Michael B.
Publication year - 2000
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/19.24.6778
Subject(s) - pdz domain , biology , activator (genetics) , microbiology and biotechnology , dna binding protein , computational biology , plasma protein binding , domain (mathematical analysis) , transcription factor , genetics , gene , mathematical analysis , mathematics
The highly conserved and ubiquitously expressed 14‐3‐3 proteins regulate differentiation, cell cycle progression and apoptosis by binding intracellular phosphoproteins involved in signal transduction. By screening in vitro translated cDNA pools for the ability to bind 14‐3‐3, we identified a novel transcriptional co‐activator, TAZ ( t ranscriptional co‐ a ctivator with PD Z ‐binding motif) as a 14‐3‐3‐binding molecule. TAZ shares homology with Yes‐associated protein (YAP), contains a WW domain and functions as a transcriptional co‐activator by binding to the PPXY motif present on transcription factors. 14‐3‐3 binding requires TAZ phosphorylation on a single serine residue, resulting in the inhibition of TAZ transcriptional co‐activation through 14‐3‐3‐mediated nuclear export. The C‐terminus of TAZ contains a highly conserved PDZ‐binding motif that localizes TAZ into discrete nuclear foci and is essential for TAZ‐stimulated gene transcription. TAZ uses this same motif to bind the PDZ domain‐containing protein NHERF‐2, a molecule that tethers plasma membrane ion channels and receptors to cytoskeletal actin. TAZ may link events at the plasma membrane and cytoskeleton to nuclear transcription in a manner that can be regulated by 14‐3‐3.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here